Back to search
FDAFDA · Food and drugs·Recall number D-0005-2017

Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86

Published October 12, 2016 · Recall initiated: August 5, 2016

Summary

FDA records drug Class III recall D-0005-2017, published October 12, 2016 and initiated August 5, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 3,569 capsules; Lot: Lot #: 34025714A, Exp. Date 12/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva North America
Distributor
Nationwide
Lot
Lot #: 34025714A, Exp. Date 12/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30 Capsules total); Rx only, TEVA PHARMACEUTICALS USA, Sellersville, PA 18960. NDC 00555-1054-86 recalled?

Yes. FDA published recall D-0005-2017 on October 12, 2016. Reported hazard: Failed Impurities/Degradation Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter